GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 0 | 20 | 7 | 33 | 3 |
| Cost of Goods | N/A | 0 | N/A | 35 | 5 |
| Gross Profit | N/A | 20 | 7 | -2 | -2 |
| Operating Expenses | 2,777 | 1,451 | 1,818 | 1,675 | 552 |
| Operating Income | -2,777 | -1,431 | -1,811 | -1,642 | -549 |
| Interest Expense | 1,724 | 849 | 7,439 | 1,518 | 3,263 |
| Other Income | 2,809 | 29,140 | -11,266 | -15,476 | -408 |
| Pre-tax Income | -1,692 | 26,860 | -20,516 | -18,636 | -4,220 |
| Net Income Continuous | -1,692 | 26,860 | -20,516 | -18,636 | -4,220 |
| Net Income | $-1,692 | $26,860 | $-20,516 | $-18,636 | $-4,220 |
| EPS Basic Total Ops | 362.61 | 5,725.11 | -4,397.25 | -5,153.10 | -0.01 |
| EPS Basic Continuous Ops | -360.05 | 5,725.29 | -4,398.75 | -5,150.78 | -0.01 |
| EPS Diluted Total Ops | 362.61 | 2,793.61 | -4,397.25 | -5,153.10 | -0.01 |
| EPS Diluted Continuous Ops | -360.05 | 2,795.56 | -4,398.75 | -5,150.78 | -0.01 |
| EBITDA(a) | $-2,088 | $-787 | $-1,411 | $-498 | $898 |